Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.31%
#2 aelf aelf +23.02%
#3 Venom Venom +14.28%
#4 Bitway Bitway +13.63%
#5 Pons Pons +10.65%
#6 Decred Decred +10.50%
#7 TRIA TRIA +9.66%
#8 Wibx Wibx +8.12%
#9 AtomOne AtomOne +7.63%
#10 DexNet DexNet +7.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Auro Laboratories Limited Auro Laboratories Limited

Auro Laboratories Limited

AUROLAB
Rank in Stocks #30668
Based in Mumbai, India, Auro Laboratories Ltd. commenced operations on May 26,... Based in Mumbai, India, Auro Laboratories Ltd. commenced operations on May 26, 1989. The company primarily deals in active pharmaceutical ingredients (APIs) and also supplies bulk drugs.
Share Price
$2.56
Last synced: 2026-08-18
Market Cap
$15.96M
Change (1 day)
-1.78%
Change (1 year)
-10.77%
Country
IN
Trade Auro Laboratories Limited (AUROLAB)

Category

Healthcare
Dividend history for Auro Laboratories Limited (AUROLAB)
Auro Laboratories Limited (stock symbol: AUROLAB) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Auro Laboratories Limited (AUROLAB) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
23.00%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT